Joki Y, Konishi H, Takasu K, Minamino T, et al. Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice. J Cardiol 2023;81:347-355.
PMID: 36244565